ABBV Summary
- NYSE >
- ABBV
| Ticker | ABBV |
|---|---|
| Description | ABBVIE INC |
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. | |
| Exchange | NYSE |
| Type | Stock |
| Sector | Healthcare |
| Employees | 2,022 |
| Next Earnings Date | November 4th, 2022 |
| Ex-Dividend Date | October 13th, 2022 |
| Yield | 4.01967% |
| Dividend | $1.41 |
| IV | 28.325825% |
| IV Percentile | 92nd |
| IV Rank | 75.24% |
| IV Skew | 7.166458 |
| IV Skew Percentile | 32nd |
| IV Skew Sentiment | Bullish |
| Option Volume | 9,425 |
| Volume | 5,751,553 |
| Price | $143.50 |
| Previous Close | $143.01 |
| 52-Week High | $175.91 |
| 52-Week Low | $105.93 |
| 50-Day Moving Avg. | $140.00 |
| 200-Day Moving Avg. | $148.38 |
| 10-Day Avg. Volume | 6,541,533 |
| 20-Day Avg. Volume | 5,274,590 |
| 30-Day Avg. Volume | 5,175,921 |
| 3-Month Avg. Volume | 5,408,378 |
| PE | 19.84583 |
| EPS | $7.07 |
| Outstanding Shares | 1,768,096,495 |
| Market Capitalization | $248,081,619,200 |
| Currency | USD |
| Updated | September 23rd, 2022 |